Oral nicotinamide may reduce the number and size of AKs and prevent the development of new non-melanoma skin cancers among patients at high risk.
While CDI is becoming more common in all hospitalized patients, patients with cancer appear to be at an elevated risk.
To help curb drug prices, a consortium of hospital groups recently announced plans to form their own nonprofit drug company.
Larotrectinib may have durable antitumor activity in patients with TRK fusion-positive cancers, regardless of tumor type.
Eighteen and 127 patients were enrolled into dose-escalation and dose expansion cohorts, respectively.
Two small studies suggest that AHCC may improve outcomes among patients with liver cancer.
Treatment chart with usual dosage, strength, and formulation of FDA approved medications for breast cancer.
Colorectal cancer treatment regimen chart.
The #MeToo movement has inspired many women to relate stories of harassment, and medicine is no exception.
While checks were documented thoroughly in 3 centers, there were no internal standards for physician checks.
The most frequently observed adverse events of any grade were neutropenia, anemia, nausea, fatigue, and thrombocytopenia.
Non-cigarette tobacco use has increased by over 100% in the last 2 decades.
Patients with HBV receiving anticancer therapy can have virus reactivation resulting from immunosuppression.
High fish consumption may provide a protective benefit against gastrointestinal cancers, thyroid cancer, multiple myeloma, and childhood leukemia.
There were no significant differences in QoL between study arms.
The novelty of immunotherapies means that physicians and patients lack extensive experience dealing with them.
Although checkpoint inhibition is altering the landscape of oncologic care, there is a low response rate to treatment.
Epidemiologic data of flaxseed dietary intake and high enterolactone serum concentrations suggest that flaxseed consumption may reduce the risk of breast cancer.
A recent study is the first to demonstrate the cumulative effect of a large number of lifestyle behaviors.
As oncologists learn to target the immune response to "self and non-self," a delicate therapy balance will eventually be achieved with predictable outcomes, benefits, and toxicity in the fight against cancer.
Epidemiologic evidence suggests that high poultry consumption is not associated with an increased risk of most cancers, including cancer mortality.
CONCORD-3 builds on data from CONCORD-2 and includes information from nearly 1 billion individuals worldwide.
TLS is considered an emergency, so it's crucial to initiate therapy as soon as possible.
Novel algorithms may be able to diagnose and plan cancer treatments more effectively than humans, but it's unclear if and when artificial intelligence will be integrated into clinical practice.
This trend may exacerbate ethnicity-associated health disparities.
Management of malignant pleural effusions should be tailored to the particular patient, depending on preference, prognosis, and variety of underlying disease.
As failure to recognize depression symptoms contributes to the association between mortality and depression in cancer patients, early recognition and treatment with pharmacologic and/or psychologic support is essential for improving outcomes.
The association of cancer risk and alcohol varies by tumor type, as alcohol consumption has been associated with several different types of cancers.
Researchers assigned 251 eligible patients to a specific treatment cohort depending on the molecular profile of their tumors.
Careful research is needed to ensure that immunotherapies activating T cells do not inadvertently fuel progression of T cell malignancies.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- Confronting Racial Disparities in Prostate Cancer Survival Outcomes
- Everolimus Plus Letrozole: An Effective First-Line Therapy for Advanced Breast Cancer
- FDA Approves Nilotinib for Pediatric Patients With CML
- Nicotinamide and Cancer
- Nivolumab Plus Ipilimumab Improves Overall Survival, ORR in Renal Cell Carcinoma
- Encorafenib, Binimetinib May Be Effective in BRAF-Mutant Melanoma